Health & Environmental Research Online (HERO)


Print Feedback Export to File
3350475 
Journal Article 
Occurrence and distribution of brominated flame retardants and perfluoroalkyl substances in Australian landfill leachate and biosolids 
Gallen, C; Drage, D; Kaserzon, S; Baduel, C; Gallen, M; Banks, A; Broomhall, S; Mueller, JF 
2016 
Yes 
Journal of Hazardous Materials
ISSN: 0304-3894
EISSN: 1873-3336 
Elsevier B.V. 
Journal of hazardous materials 
312 
55-64 
English 
The levels of perfluroalkyl substances (PFASs), polybrominated diphenyl ethers (PBDEs) and hexabromocyclododecane (HBCDDs) were studied in Australian landfill leachate and biosolids. Leachate was collected from 13 landfill sites and biosolids were collected from 16 wastewater treatment plants (WWTPs), across Australia. Perfluorohexanoate (PFHxA) (12-5700ng/L) was the most abundant investigated persistent, bioaccumulative and toxic (PBT) chemical in leachate. With one exception, mean concentrations of PFASs were higher in leachate of operating landfills compared to closed landfills. Polybrominated diphenyl ethers (PBDEs) and hexabromocyclododecane isomers (HBCDDs) were detected typically at operating landfills in comparatively lower concentrations than the PFASs. Decabromodiphenyl ether (BDE-209) (<0.4-2300ng/g) and perfluoroctanesulfonate (PFOS) (<LOD-380ng/g) were the predominant PBTs detected in biosolids. Using data provided by sites, the volume of leachate discharged to WWTPs for treatment was small (<1% total inflow), and masses of PBTs transferred reached a maximum of 16g/yr (PFHxA). A national estimate of masses of PBTs accumulated in Australian biosolids reached 167kg/yr (BDE-209), a per capita contribution of 7.2±7.2mg/yr. Nationally, approximately 59% of biosolids are repurposed and applied to agricultural land. To our knowledge this study presents the first published data of PFASs and HBCDDs in Australian leachate and biosolids. 
FATE 
IRIS
• Hexabromocyclododecane (HBCD)
     New 7/2016 (private)
     Database Searches
          Pubmed
     Excluded/Not on Topic
OPPT REs
• OPPT_Cyclic Aliphatic Bromine Cluster (HBCD)_C. Engineering
     Data screening total
          Screening: Excluded
• OPPT_Cyclic Aliphatic Bromine Cluster (HBCD)_D. Exposure
     Total – title/abstract screening
          Off topic
• OPPT_Cyclic Aliphatic Bromine Cluster (HBCD)_E. Fate
     Total – title/abstract screening
          Off topic
• OPPT_Cyclic Aliphatic Bromine Cluster (HBCD)_F. Human Health
     Total – title/abstract screening
          Off topic
PFAS
• Additional PFAS (formerly XAgency)
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
               WOS
     PFHxA (307-24-4)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search August 2019
          PubMed
     Not prioritized for screening
     Perfluorooctanesulfonic acid
• PFBA
     Protocol References
• PFHxA
     Literature Search
          Pubmed
          WOS
     LitSearch Update: February 2018
          Term Set 2: Initial Search
               PubMed
               WoS
     Literature Search
          Pubmed
          WOS
     Scopus: April 2021
     Screening Results
          Excluded/Not on Topic
     Title and Abstract Screening
          Excluded
               Not relevant to PECO
     HAWC
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
     Literature Search Update (2013-2019)
          PubMed
          WOS